Today's story
ADARx Raises $446 Million in Upsized IPO
ADARx Pharmaceuticals raised $446 million in an upsized IPO at $17 a share, the top of its range, and began Nasdaq trading under ADRX with an AbbVie private placement.
Business · 7 sources · 1dRead it
The journal
Open the journal →The conversation starts in the journal — be the first to post.
About PRXL2A
Peroxiredoxin-like 2A is a protein that in humans is encoded by the PRXL2A gene. PRXL2A is also known as redox-regulatory protein FAM213A and peroxiredoxin-like 2 activated in M-CSF stimulated monocytes (PAMM).
Everything about PRXL2A →